Today: 1 May 2026
Browse Category

NASDAQ:TXN 20 July 2025 - 8 December 2025

Texas Instruments (TXN) Stock on December 8, 2025: Q3 Beat, $60 Billion U.S. Fab Plan and What Wall Street Expects Next

Texas Instruments (TXN) Stock on December 8, 2025: Q3 Beat, $60 Billion U.S. Fab Plan and What Wall Street Expects Next

Texas Instruments shares closed at $180.67 on December 8, 2025, down about 16% from a year earlier. Q3 revenue rose 14% year-over-year to $4.74 billion, beating forecasts, while earnings matched estimates at $1.48 per share. The company faces margin pressure and cautious guidance amid heavy capital spending. Market cap stands near $160–166 billion.
Texas Instruments (TXN) Surges Toward $182 as Big Investors, Rich Dividend and $60B Fab Bet Drive December Rally

Texas Instruments (TXN) Surges Toward $182 as Big Investors, Rich Dividend and $60B Fab Bet Drive December Rally

Texas Instruments shares jumped nearly 4% to around $182 by mid-afternoon Wednesday, extending a two-week rally that has lifted the stock more than 13%. Recent filings show major funds including Norges Bank and Invesco increasing stakes, with institutions now holding about 85% of the float. Q3 revenue rose 14.2% to $4.74 billion, but Q4 guidance missed expectations. TXN remains below its 52-week high of $221.69.
Texas Instruments (TXN) Stock on December 1, 2025: Earnings Hangover, $60 Billion Fab Bet and What Wall Street Expects Next

Texas Instruments (TXN) Stock on December 1, 2025: Earnings Hangover, $60 Billion Fab Bet and What Wall Street Expects Next

Texas Instruments shares traded near $168 on December 1, 2025, valuing the company at about $152 billion, down roughly 10% year-to-date and 16% over 12 months. Q3 revenue rose 14% to $4.74 billion, beating estimates, but the stock remains below its 52-week high as investors weigh heavy spending and a softer earnings outlook.
Texas Instruments (TXN) Stock Outlook Before the December 1, 2025 Open: Rally, Analyst Downgrades and Fresh Institutional Buying

Texas Instruments (TXN) Stock Outlook Before the December 1, 2025 Open: Rally, Analyst Downgrades and Fresh Institutional Buying

Texas Instruments shares closed at $168.27 on Friday, up 1.77% and marking a fifth straight gain, but remain over 24% below their July peak. Trading volume was about half its 50-day average. The stock outperformed major chip peers as investors weighed a recent earnings beat against cautious Q4 guidance and ongoing weak analog chip demand. Institutional activity increased between November 28 and 30.
30 November 2025
Texas Instruments (TXN) Stock Extends Rally as Citi Reaffirms Buy and Big Funds Adjust Positions

Texas Instruments (TXN) Stock Extends Rally as Citi Reaffirms Buy and Big Funds Adjust Positions

Texas Instruments shares rose 1.77% to $168.27 on Friday, marking a fifth straight gain and outperforming major U.S. indexes and most large chip peers. Trading volume was light in the post-Thanksgiving half session. Citi reiterated a Buy rating with a $235 price target and highlighted the company’s new 900,000-square-foot assembly plant in Melaka, Malaysia. TXN remains below its 52-week high of $221.70.
29 November 2025
Texas Instruments (NASDAQ: TXN) Stock Surges on Dividend Hike, Then Plummets on Weak Outlook – Is a Slow Recovery Ahead?

Texas Instruments (NASDAQ: TXN) Stock Surges on Dividend Hike, Then Plummets on Weak Outlook – Is a Slow Recovery Ahead?

Texas Instruments reported Q3 2025 revenue of $4.74 billion, topping estimates, but issued weak Q4 guidance, sending shares down about 7% after hours. The company raised its quarterly dividend 4% to $1.42 per share, marking 22 consecutive annual increases. CEO Haviv Ilan will become chairman in 2026 as Rich Templeton retires. TI’s core markets remain sluggish despite strong demand for AI chips elsewhere in the sector.
22 October 2025
Investors Beware: 7 Stocks to Avoid on October 22, 2025 Amid Alarming Warnings

Investors Beware: 7 Stocks to Avoid on October 22, 2025 Amid Alarming Warnings

Netflix shares fell over 6% after missing earnings due to a Brazilian tax charge. Texas Instruments warned of weak demand, pushing its stock down 7.6% and dragging chipmakers lower. Target neared multi-year lows as sales dropped and its CEO resigned. The Buffett Indicator hit 219%, with top bankers warning of overvalued markets and possible correction.
Texas Instruments Stock Surges on Dividend Boost — But Analysts Warn of a “Slow Recovery”

Texas Instruments Stock Surges on Dividend Boost — But Analysts Warn of a “Slow Recovery”

Texas Instruments reported Q3 2025 earnings of $1.48 per share on $4.74 billion revenue, narrowly beating forecasts. The company issued a cautious Q4 outlook, sending shares down 8% in after-hours trading. TI raised its quarterly dividend 4% to $1.42 and announced CEO Haviv Ilan will become chairman in 2026. The stock trades at a premium to peers and is roughly flat for the year.
22 October 2025
Texas Instruments (TXN) Stock Price Today Soars Amid Dividend Hike & AI Boom: Rally Ahead or More Pain? 🎯

Texas Instruments Stock Soars on Dividend Hike, Then Plunges on Weak Guidance – What’s Next for TXN?

Texas Instruments reported Q3 revenue of $4.74 billion, beating estimates, but issued weaker-than-expected Q4 guidance. Shares fell 6–8% after hours to around $168. The board raised the dividend 4% to $1.42 per share, marking 22 consecutive annual increases. Bank of America and Mizuho downgraded the stock, citing tariff risks and limited AI exposure.
21 October 2025
Texas Instruments (TXN) Stock Price Today Soars Amid Dividend Hike & AI Boom: Rally Ahead or More Pain? 🎯

Texas Instruments (TXN) Stock Price Today Soars Amid Dividend Hike & AI Boom: Rally Ahead or More Pain? 🎯

Texas Instruments closed at $176.58 Friday, lagging the chip sector rally as the PHLX Semiconductor Index nearly doubled in 2025. Q3 earnings are due Oct. 21, with analysts expecting flat results. Bank of America downgraded TXN to “Underperform,” citing valuation and weak industrial demand. The company raised its dividend to $1.42 and announced CEO Haviv Ilan will become chairman in 2026.
19 October 2025
Shockwaves in Silicon: Global Chip Industry’s Two-Day Upheaval (July 23–24, 2025)

Shockwaves in Silicon: Global Chip Industry’s Two-Day Upheaval (July 23–24, 2025)

SK Hynix posted record Q2 results, with operating income up 69% to ₩9.2 trillion and revenue up 35% to ₩22.2 trillion, overtaking Samsung as the world’s top memory chipmaker on HBM demand. Intel is shifting from the 18A to 14A process under new CEO Lip-Bu Tan and is expected to post its sixth straight quarterly net loss. Nvidia’s H20 AI chip sales to China resumed after U.S. approval, boosting TSMC demand.
Global Tech Roundup: Space Triumphs, Cyber Breaches & Gadget Surprises Rock July 22–23, 2025

Global Tech Roundup: Space Triumphs, Cyber Breaches & Gadget Surprises Rock July 22–23, 2025

Gearbox CEO Randy Pitchford said Borderlands 4 will launch on Nintendo Switch 2 on October 3, 2025, running at about 30fps for feature parity. Google released a Pixel 10 Pro teaser ahead of its August 21 launch, promising camera upgrades and Android 16. Texas Instruments warned new U.S. chip tariffs could hit demand, sending shares down 12%. TSMC posted a 60% profit jump but warned of tariff and currency risks.
Google Glass: From Futuristic Hype to Privacy Nightmare to Enterprise Hero (2025 Update)

Google Glass: From Futuristic Hype to Privacy Nightmare to Enterprise Hero (2025 Update)

Google announced Google Glass in April 2012 and began Explorer Edition shipments in April 2013 at $1,500. Time named it Invention of the Year in 2012, but privacy concerns and bans followed. Google halted consumer sales in January 2015, shifted to enterprise use, and released Glass Enterprise Edition 2 in 2019. Sales and support ended in 2023, with the project canceled the same year.
1 4 5 6

Stock Market Today

  • Avalyn Pharma Rings Nasdaq Opening Bell Highlighting Pulmonary Fibrosis Treatment Advances
    April 30, 2026, 6:32 PM EDT. Avalyn Pharma (Nasdaq: AVLN) marked a milestone by ringing the Opening Bell at Nasdaq MarketSite in Times Square. CEO Lyn Baranowski led the ceremony, spotlighting the company's efforts to develop optimized inhaled formulations of antifibrotic drugs. These medicines target pulmonary fibrosis, a rare and serious respiratory disease. Avalyn aims to transform treatment paradigms with these innovations. The event underscores Avalyn's focus on rare lung conditions and growing presence in the biotech sector.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
Go toTop